Chamalières, France

Etienne Merlin



 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Etienne Merlin: Innovator in Allergy Treatment

Introduction

Etienne Merlin is a notable inventor based in Chamalières, France. He has made significant contributions to the field of allergy treatment, particularly concerning peanut allergies. His innovative approach has led to the development of a unique gastrointestinal release capsule designed to help patients with peanut allergies.

Latest Patents

Merlin holds a patent for a gastrointestinal release capsule intended for use in a method for desensitizing and/or inducing tolerance in a patient with a peanut allergy. This capsule is specifically designed for oral use and can also be utilized for diagnosing peanut allergies. The capsule features a shell and a core, with the core containing a composition of peanut, at least one oil, and at least one first pulverulent excipient, along with an optional second prebiotic excipient. The capsule is ingested in an unopened form, ensuring the integrity of its contents until consumption.

Career Highlights

Throughout his career, Etienne Merlin has worked with esteemed institutions such as the Centre Hospitalier et Universitaire de Clermont-Ferrand and Université Clermont Auvergne. His work in these organizations has allowed him to collaborate with other professionals in the field and further his research on allergy treatments.

Collaborations

Merlin has collaborated with notable colleagues, including Jean-Luc Fauquert and Bertrand Evrard. Their combined expertise has contributed to advancements in allergy research and treatment methodologies.

Conclusion

Etienne Merlin's innovative work in developing a gastrointestinal release capsule for peanut allergy treatment showcases his dedication to improving patient outcomes. His contributions to the field of allergy treatment are significant and reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…